W
Whitehawk Therapeutics, Inc. (WHWK)
NCM – Real Time Price. Currency in USD
3.92
+0.12 (3.16%)
At close: May 12, 2026, 4:00 PM EDT
3.92
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.92
+0.12 (3.16%)
At close: May 12, 2026, 4:00 PM EDT
3.92
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.36 | 6.05 | 10 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 15M | 24M | 26M | 7M | N/A |
| Gross Profit | 14M | 22M | 23M | 6M | -22K |
| Operating Income | -59M | -72M | -65M | -114M | -123M |
| Net Income | -61M | -66M | -64M | -21M | -116M |
| EBITDA | -59M | -72M | -65M | -114M | -99M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 56.05 | 5.5 |
| Next quarter | N/A | -36.15 | 1.0 |
| Current year | -100 | -307.88 | 1.0 |
| Next year | N/A | 1.37 | 2.0 |
| Weighted average score | 2.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 4.55 | 5.88 | -12.06 | 5.0 |
| Y/Y | -99.99 | -130.39 | -117.48 | -13.08 | 1.0 |
| 3y average | -1.9 | 20.71 | 32.86 | -27.76 | 5.5 |
| 5y average | 232.1 | -591.62 | -110.07 | -56.61 | 3.3 |
| Weighted average score | 3.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $34.8M barely cover the upcoming debt maturities $0.0
Total current assets $125.5M exceed Total current liabilities $11.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns